The objective of the study was to develop and validate simple, authentic and stability indicating high performance thin-layer chromatographic method for determination of Canagliflozin in bulk and pharmaceutical formulations as per ICHQ2 R1 Guidelines. HPTLC aluminium plates Precoated with Silica Gel 60F254 using Toluene: Ethyl acetate: Methanol (2:2:1, v/v/v) as mobile phase were used for the chromatographic separation and it was validated with different parameters such as Linearity, Precision, Accuracy, Robustness, Ruggedness, Limit of Detection (LOD) and Limit of Quantification (LOQ). Also, Forced degradation study was carried out in different mediums. The densitometric analysis of the spots was performed at 290 nm. A Linear data over the range of 10-500ng/spot with a good correlation coefficient of 0.9988 unfolds linear relationship between area and concentration in calibration curve. The LOD and LOQ were found to be 0.39 and 1.19 respectively. A recovery of Canagliflozin in tablet formulation was observed in the range of 99.04-99.82%. Percentage assay of Canagliflozin tablets (INVOKANA ® ) was found to be 99.8%. Forced degradation studies of canagliflozin showed the degradation in acidic, alkaline, photolytic and oxidation but were most stable in thermal degradation. The proposed method is definite, meticulous and reproducible and can be used for routine analysis of Canagliflozin in bulk and pharmaceutical dosage form.
INTRODUCTION
Canagliflozin is an oral selective Sodium-Glucose cotransporter 2 (SGLT2) inhibitor used for the management of type 2 Diabetes Mellitus (Elkinson et al., 2013) . The chemical name (IUPAC) of Canagliflozin is (2S,3R,4R,5S,6R)-2-{3-[5-(4-fluoro-phenyl)-thiophen-2-ylmethyl]-4-methyl-phenyl} -6-hydroxymethyltetrahydro-pyran-3,4,5-triol with molecular formula C 24 H 25 FO 5 S. It is white to off white solid with melting point of 95-105ºC. It is soluble in many organic solvents (methanol, Dimethyl sulfoxide) but insoluble in aqueous media.
It curbs the transporter protein SGLT2 present in the proximal tubules of the kidney which curtails renal glucose absorption, thereby increasing urinary glucose excretion and lowering blood glucose levels.
It is a product of Mitsubishi Tanabe Pharma and Janssen Pharmaceuticals, a division of Johnson and Johnson (Neumiller et al., 2010; Singh et al., 2015; Song et al., 2014) . As per the Literature Survey, it is revealed that the drug has been estimated by Liquid chromatography and Ultra High Performance Liquid Chromatography-Mass Spectroscopy (UHPLC-MS) in biological fluids like human and rat plasma. Bulk drug and its marketed formulation has been analyzed by Ultraviolet Spectroscopic but no High Performance thin layer Chromatography analysis has been reported for the estimation in bulk and pharmaceutical dosage forms . 
MATERIALS AND METHODS

Instrumentation
The HPTLC system (CAMAG, Switzerland) consisted of Linomat V auto sampler connected to a nitrogen cylinder, a twin trough chamber (20 × 10cm), a derivatisation chamber, a plate heater, TLC Scanner IV (Camag Muttenz, Switzerland), UV cabinet with dual wave length UV lamps and win CATS software were used for chromatographic study. Electronic analytical balance (Shimadzu AUX-220) was used for all the weighing purpose.
Chemicals and reagents
Analytically The HPTLC analysis was performed on Pre-coated Silica Gel 60 F 254 HPTLC plates (20 × 10 cm, layer thickness 0.2 mm (E. Merck KGaA, Darmstadt, Germany). HPTLC plates were prewashed with 10 mL of methanol and activated at 80ºC for 5 min before application of sample. The standard and formulation samples of Canagliflozin were spotted using a Linomat 5 auto sampler fitted with a 100 L Hamilton syringe (CAMAG, Muttenz, Switzerland) and operated with settings of a band length of 3.5 mm; band distance of 7.2 mm; distance from the side of plate of 10mm; and distance from the bottom of the plate of 10 mm. The plates were developed to a distance of 70mm in a mobile phase consisting of Toluene: Ethyl acetate: Methanol (2:2:1 v/v/v) and development was carried out in twin trough chamber (20 x 10 cm) presaturated with the mobile phase. The developed HPTLC plates were air dried and densitometric scanning was performed on CAMAG TLC scanner III in absorbance mode equipped with WINCATS planar chromatography manager (version 1.4.6) software. The spots were analyzed at a wavelength of 290nm. The scanning of the spots was done at a rate of 20mm/s. Evaluation was performed using linear regression analysis via peak areas.
Preparation of solutions Preparation of stock solution
Accurately weighed quantity of Canagliflozin (10 mg) was transferred to a 10 ml volumetric flask, dissolved and diluted up to the mark with methanol (Concentration:1000 µg/ml) ( Skoog DA et al.,2007) .
Preparation of standard working solution
It was prepared by taking 0.1 ml of stock solution into 1 ml volumetric flask and the final volume was made up with 0.9 ml of methanol (100 µg/ml) (Skoog DA et al.,2007) .
Preparation of mobile phase
The mobile phase was prepared by mixing Toluene, Ethyl acetate and Methanol in the ratio of 2:2:1 v/v/v.
Preparation of sample solution for Force degradation studies
To assess the stability indicating property of the developed HPTLC method, stress studies were carried out under ICH recommended conditions. Forced degradation of Canagliflozin was carried by exposing the bulk sample to acidic, alkaline, oxidative, photolytic, dry heat and neutral conditions. The aim was to study the ability of the proposed method to measure the analyte response in presence of its degradation products (Rajput DK et al., 2013) .
Acid and alkali hydrolysis
Aliquot of 1 ml of Canagliflozin solution (10 mg dissolved in 10 ml i.e. 1 mg/ml) was transferred to a small round bottom flask and it was mixed with 9 ml of 0.1N hydrochloric acid or 0.1N sodium hydroxide. The prepared solutions were subjected to reflux for 2 h in a boiling water bath. The samples were cooled to room temperature (25ºC), neutralized with an amount of acid or base equivalent to that of the previously added. From the resulting neutral solution, 5µl/spot was applied at TLC plate with the help of applicator.
Oxidation
Aliquot of 1 ml of Canagliflozin solution (10 mg dissolved in 10 ml i.e. 1 mg/ml) was transferred to round bottom flask and it was mixed with 9 ml of 30% hydrogen peroxide solution, the reaction mixture was allowed to proceed at room temperature (25ºC) for 2 h with intermittent shaking. A volume of 5µl/spot was applied at TLC plate with the help of applicator.
Irradiation with ultraviolet light
A sample powder of Canagliflozin (10 mg) was exposed to UV light (254 nm) for 48 h. The material was dissolved in 10 ml water. The solution was claimed to have concentration of 1 mg/ml. A volume of 5µl/spot was applied at TLC plate with the help of applicator. As well as, an aqueous solution of Canagliflozin (1 mg/ml) was exposed to UV light (254 nm) for 48 h, and after that a volume of 5µl/spot was applied at TLC plate with the help of applicator.
Thermal degradation
A sample powder of Canagliflozin (10 mg) was exposed to a temperature of 70ºC for 48 h in hot air oven. The material was dissolved in 10 ml methanol. The solution was claimed to have concentration of 1 mg/ml. A volume of 5µl/spot was applied at TLC plate with the help of applicator.As well as, an aqueous solution of Canagliflozin (1 mg/ml) was exposed to a temperature of 70ºC for 48 h, and after that a volume of 5µl/spot was applied at TLC plate with the help of applicator.
Preparation of sample solution for assay of marketed formulations
Twenty INVOKANA ® tablets were weighed, average weight was calculated, and were triturated to fine powder. A powder proportionate to 10mg was taken in a 10ml volumetric flask to which meager amount of methanol was added. The flask is then ultra-sonicated for 15 minutes and volume is made up with methanol. The tablet solution is then filtered through whatman filter paper (No.41) and from the above solution, 1μl of solution containing 1000ng/band was applied on the HPTLC plate with the help of Linomat V auto sprayer in 3 replicates. The plate was developed and studied under earlier expressed chromatographic conditions.
Analysis of forced degradation samples
Analysis of the degraded sample solutions was done by applying 5μl with the help of auto sampler to same TLC plate in duplicate. The plate was developed, dried and analyzed as described earlier in chromatographic conditions.
Preparation of Calibration Curve
Aliquots of 0.1, 0.2, 0.4, 0.5,1,2,4 and 5μl of standard working solution of Canagliflozin were spotted on HPTLC plate using 100μL Hamilton syringe with the help of Linomat V auto sprayer to obtain a concentration of 10-500 ng/spot. The plate was developed, dried and analyzed at 290nm with the help of TLC Scanner 3 using Win-CATS software.
Sets of calibration curves were constructed and the area report was recorded. A plot of concentration versus area under curve was established (10-500 ng/spot).
RESULTS AND DISCUSSION
Analytical Method Validation
The developed method was validated for different parameters like linearity, precision, accuracy, specificity, ruggedness, robustness, LOD and LOQ as per ICH Q2A and Q2B guidelines (Validation of Analytical Procedures: Text and Methodology Q2 (R1), Geneva, 2005).
Linearity
Linear regression data over the range of 10-500ng/spot for Canagliflozin with a correlation coefficient of 0.9988 unfolds good linear relationship between area and concentration in calibration curve. 
Accuracy
Accuracy of the method was resolved by standard addition method in which standard addition of pure API at three different concentration levels of 50%, 100% and 150% was performed in triplicate. Table 1 presents accuracy of the method in the terms of % recovery of the API. 
Precision
Precision of the method was determined by evaluating intraday and interday precision. Intra-day and Inter-day variation was analyzed by selecting three concentrations which were 20, 100 and 400ng from linearity range. Intraday analysis was carried on same day whereas Interday analysis was carried on three different days in replicates of three. The respective peak areas for different concentrations were reported . Table 2 & 3 express precision data for the method in terms of % RSD. 
Specificity
The specificity of the method was evaluated by separating the peaks of both tablet and API. The spot of Canagliflozin in the sample was proved by matching the R f and spectra of the standard spot. Therefore, the method was considered to be specific. Figure 4 shows the chromatogram of Canagliflozin tablets.
Robustness
Robustness of the method was ascertained by deliberately altering the chromatographic conditions. A change in the mobile phase composition and change in wavelength were selected as parameters and were varied separately whereas all other conditions were held constant as described in the method. No difference was observed in the peak area and R f values. Table 4 indicates robustness of the method. 
Ruggedness
Ruggedness of the method was performed by carrying out the method with the help of two different analysts. Table 5 explains the ruggedness of the method in terms of %RSD. 
Detection limit and Quantification Limit
A limit of detection (LOD) and a limit of quantification (LOQ) were calculated according to the formula: LOD = 3.3 σ/s LOQ = 10 σ/s Where, 'σ' is the standard deviation of 'y' intercept of regression line and 's' is the slope of the calibration curve. The LOD and LOQ values were found to be 0.39 and 1.19 respectively Table 6 displays that the %Mean recovery in formulation is 99.8 and %relative standard deviation is less than 2% which is within the limits. 
Assay of the Pharmaceutical Dosage Form
Analysis of forced degradation samples of Canagliflozin
From this forced degradation, it was clear that in case of thermal stability Canagliflozin was most stable under the employed stress conditions as shown in table 7. In case of acid hydrolysis, alkaline hydrolysis and oxidation degradation was observed and is shown in the respective chromatograms but maximum degradation was seen on irradiation with U.V. light. Nonetheless, the method was able to separate isolate the degradation products from the intact drug. This confirmed the stability indicating property of the developed method. The concentration of the produced degradation products analogous to the intact Canagliflozin was determined and found to be 23. 77%, 20.16%, 28.11%, 26.36%, 16 .24% in case of acid hydrolysis, alkaline hydrolysis ,oxidation, photolytic and thermal stability respectively as shown in Table 7 . Figure 6 presents chromatograms showing forced degradation of Canagliflozin.
1-Chromatogram of Acid treated
Canagliflozin. The method explained in the current work provides an agreeable, definite and meticulous way for analysis of Canagliflozin in bulk and pharmaceutical dosage form by high performance thin layer chromatography (Table 7) . Development of TLC procedure was done for the determination of Canagliflozin. The mobile phase consisting of Toluene: Ethyl acetate: Methanol in the ratio of 2:2:1(v/v/v) culminated into favorable resolution, sharp and symmetrical peaks at R f 0.41. Linear regression data over the range of 10-500ng/spot for Canagliflozin with a correlation coefficient of 0.9988 was unfolded by regression analysis. % RSD for all the parameters was found to be less than 2%. Percentage recovery for Canagliflozin was found within the range of 99.04-99.82%. The LOD and LOQ values were found to be 0.39 and 1.19 respectively. The assay for Canagliflozin was found to be 99.8 ± 0.02. Specificity of the proposed method was confirmed when the formulation was spotted on the HPTLC plates, developed and scanned and the excipients did not interfere with the sample peak. Table 8 portrays all the standard and validation parameters along with the results obtained. 
2-Chromatogram of Alkali treated
CONCLUSION
It is found that the developed HPTLC technique is quite simple, authentic, definite, reproducible, sensitive, favorable, specific and economical. It can become efficient analytical tool for routine quality control of Canagliflozin in bulk drug and its pharmaceutical dosage forms.
